Emerson's Q3 FY2026 EPS rose 24% to $1.28, but an $82 million tariff refund accounts for nearly half the gain — strip it out and underlying earnings grew 13%, solid rather than spectacular. That one-line item, booked in cost of sales after the U.S. Supreme Court struck down IEEPA tariff authority, accounts for essentially the entire 1.9-percentage-point gross-margin gain. The more durable story: segment profit grew 10.2 percent on 7.0 percent sales growth, the long-troubled Test & Measurement unit finally turned a profit, and a $9.6 billion backlog with 10 percent underlying U.S. growth points to real mid-cycle momentum — set against a Europe that shrank and a China that went backwards.
1. Consolidated Balance Sheet
1-1. Major asset movements (Sept 30, 2025 → June 30, 2026)
| Item | Sept 30, 2025 ($M) | June 30, 2026 ($M) | Change |
|---|---|---|---|
| Cash and equivalents | 1,544 | 2,180 | +41.2% |
| Receivables, net | 3,101 | 3,057 | -1.4% |
| Inventories | 2,213 | 2,513 | +13.6% |
| Property, plant and equipment, net | 2,871 | 2,861 | -0.3% |
| Goodwill | 18,193 | 18,122 | -0.4% |
| Other intangible assets, net | 9,458 | 8,686 | -8.2% |
| Total assets | 41,964 | 42,208 | +0.6% |
Two movements deserve attention. Receivables fell 1.4 percent while sales grew, which means cash is coming in faster than the business is growing. That is a genuinely good sign.
Inventory is the harder call. It rose 13.6 percent across all categories: raw materials and work-in-process climbed from $1,693 million to $1,917 million (+13.2%), while finished goods rose from $520 million to $596 million (+14.6%) — the two categories grew at nearly identical rates. A broad-based build is typically consistent with filling orders rather than unsold overstock. The $9.6 billion backlog supports that reading, as does management's comment about increased greenfield project activity. The counter-argument is real though: Europe sales were down 1 percent on an underlying basis and China fell 3 percent, so some of this build is being financed against soft demand in two large regions.
The intangibles decline is amortization, not impairment — and it comes from two deals, not one. Segment disclosure shows nine-month amortization of $322 million at Test & Measurement (the NI acquisition, per the 10-Q's identification of this segment's portfolio as "the NI brand") against $303 million at Control Systems & Software, which itself blends AspenTech with legacy DeltaV and Ovation assets. Gross intangibles barely moved, from $15,832 million to $15,772 million, while accumulated amortization jumped from $6,374 million to $7,086 million. Within the net balance, customer relationships fell from $5,801 million to $5,375 million and intellectual property from $3,411 million to $3,052 million. Nine-month intangible amortization totaled $761 million, down from $826 million — the decline is driven primarily by lower CS&S amortization as AspenTech backlog charges roll off ($370 million to $303 million), while NI-related amortization at Test & Measurement held roughly flat at $322 million versus $318 million. This drag is already easing, though charges from both acquisitions will continue for years.
Lease accounting is unremarkable: operating right-of-use assets of $666 million against $142 million current and $547 million non-current lease liabilities.
Debt maturity note. The 10-Q gives no full maturity table. What is disclosed: Emerson repaid €500 million of 1.25% notes that matured in October 2025, and the March 2025 issuance that funded AspenTech runs long — €500 million at 3.0% due 2031, $500 million at 5.0% due 2035, and €500 million at 3.5% due 2037. Near-term refinancing risk therefore sits almost entirely in commercial paper, backed by $5.5 billion of committed facilities ($2.0 billion 364-day signed February 10, 2026, plus $3.5 billion five-year from February 2023). Neither facility has ever been drawn. Notably, the fair value of long-term debt was approximately $6.8 billion — $762 million below the carrying value of $7,526 million — because the coupons are cheap relative to today's market rates, a quiet economic win for the borrower.
1-2. Financial debt vs. operating liabilities
Financial debt was essentially flat in total but shifted in shape. Short-term borrowings and current maturities rose 16.5 percent to $5,587 million, while long-term debt fell 9.5 percent to $7,526 million. Total debt of $13,113 million is virtually unchanged from $13,116 million. The euro note repayment moved funding into commercial paper. Total debt-to-total capital of 39.2 percent and net debt-to-net capital of 34.9 percent both improved from year-end. Net interest expense grew from $145 million to $258 million over nine months — the delayed cost of the AspenTech borrowing — squeezing interest coverage, though it remains at comfortable levels.
Operating liabilities tell the demand story. Accounts payable rose 16.5 percent to $1,613 million, moving in step with the inventory build. Customer advances — cash collected before revenue is earned — rose from $1,105 million to $1,224 million. Unbilled receivables rose from $1,891 million to $2,011 million, leaving net contract assets flat at $787 million.
1-3. Capital structure
Paid-in capital is trivial next to accumulated profit. Common stock of $477 million plus additional paid-in capital of $111 million totals $588 million, against retained earnings of $41,582 million. Treasury stock of $20,896 million is roughly 35 times paid-in capital. Common stockholders' equity of $20,379 million is almost entirely self-funded from decades of retained profit. This is a conservative structure by any measure.
2. Consolidated Statement of Earnings
2-1. Third quarter results
| Item | Q3 FY2025 ($M) | Q3 FY2026 ($M) | Change |
|---|---|---|---|
| Net sales | 4,553 | 4,873 | +7.0% |
| Gross profit | 2,393 | 2,655 | +10.9% |
| Gross margin | 52.6% | 54.5% | +1.9pt |
| SG&A | 1,266 | 1,343 | +6.1% |
| SG&A as % of sales | 27.8% | 27.6% | -0.2pt |
| Pretax earnings, continuing ops | 734 | 916 | +24.8% |
| Earnings from continuing ops (common) | 580 | 718 | +23.8% |
| Net margin | 12.7% | 14.7% | +2.0pt |
| Diluted EPS, continuing ops | $1.03 | $1.28 | +24.3% |
Separating one-time from recurring. The $82 million tariff refund is the single largest swing factor and it is not repeatable. Management explicitly declined to book any benefit for additional refunds still potentially owed, calling the timing and amount uncertain. Remove it and pretax earnings from continuing operations were $834 million rather than $916 million — growth of 13.6 percent, not 24.8 percent. Gross margin ex-refund was 52.8 percent, up just 0.2 points rather than 1.9.
The refund also lands entirely in Corporate and Other, not in any segment. That makes segment profit the cleanest read on the operating business: $945 million to $1,041 million, up 10.2 percent. In fact, excluding the refund, Corporate and Other got slightly worse, moving from negative $72 million to negative $83 million.
Operating leverage. Comparing that clean segment profit growth to sales growth, each 1 percent of sales growth converted into about 1.5 percent of segment profit growth. That is respectable operating leverage — the effect where fixed costs stay put while revenue rises, so profit grows faster than sales — but it is not the 3.5x the headline EPS implies.
Adjusted numbers, and what they exclude. Emerson's adjusted diluted EPS was $1.71, up 13 percent from $1.52. That measure removes intangible amortization, restructuring and related costs, acquisition and divestiture fees, discrete taxes — and, importantly, it also removes the $82 million tariff refund as a $0.11 subtraction. Adjusted EBITA was $1,303 million, up 10 percent, with margin of 26.7 percent against 26.0 percent. So on the company's own preferred measure, margin expanded 0.7 points, not 1.9. The gap between +24 percent GAAP EPS and +13 percent adjusted EPS is the whole story of this quarter in one comparison.
Emerson's own EPS bridge is revealing: operations contributed the full $0.19 of adjusted EPS growth, while the non-operating items — currency tailwind, share-count reduction, and stock compensation expense — roughly netted against each other. Buybacks are not doing the heavy lifting here. The earnings growth is operational.
2-2. Fixed cost leverage and cost structure
SG&A grew 6.1 percent against 7.0 percent sales growth, trimming the expense ratio 0.2 points. Management credits both volume leverage and cost reduction actions. Those actions carry a price: restructuring expense in other deductions jumped from $37 million to $87 million in the quarter, and from $70 million to $141 million over nine months, with a further $23 million sitting in cost of sales and SG&A. Full-year restructuring is guided to roughly $185 million. The restructuring liability grew from $120 million to $158 million, so cash outflow continues into fiscal 2027.
The heaviest genuinely fixed cost is acquisition-related amortization — $761 million over nine months, of which $148 million runs through cost of sales. Net interest expense of $258 million for nine months, up from $145 million, is the other structural burden from the AspenTech deal.
3. Consolidated Cash Flows (nine months)
| Item | 9M FY2025 ($M) | 9M FY2026 ($M) | Change |
|---|---|---|---|
| Operating cash flow (continuing operations) | 2,664 | 2,902 | +$238 |
| Capital expenditures | (263) | (284) | +$21 |
| Free cash flow | 2,401 | 2,618 | +$217 |
| — Memo: Total OCF incl. discontinued ops | 2,088 | 2,902 | +$814 |
| Investing activities | (393) | (322) | +$71 |
| Financing activities | (3,019) | (1,920) | +$1,099 |
| Ending cash | 2,219 | 2,180 | -$39 |
The memo total OCF jump of $814 million overstates the improvement on a comparable basis. Most of it is the absence of a prior-year item: Emerson paid $585 million of income taxes in Q2 FY2025 on the Copeland stake sale, which sat in discontinued operations. On a continuing-operations basis the gain is $238 million.
Quality of earnings. Operating cash flow from continuing operations divided by continuing-operations earnings was 1.49x this year against approximately 1.66x last year. Both sit comfortably above 1.0, which is what you want — profits are converting to cash. But this ratio is structurally flattered at Emerson, because $1,105 million of depreciation and amortization, mostly non-cash acquisition amortization, gets added back. The year-over-year decline comes from working capital, which consumed $320 million versus $80 million last year. Inventory alone absorbed $311 million, partly offset by $221 million from payables.
Capital intensity is low. Capital expenditures were $284 million, just 2.1 percent of sales. This is an asset-light business, and the full-year plan of roughly $0.45 billion is maintenance-plus-modest-growth, not a build cycle.
Capital returns. Financing outflows fell by more than $1 billion, but only because last year included the $7,244 million AspenTech buy-in. This year Emerson spent $898 million on buybacks and $935 million on dividends. The dividend per share rose 5.2 percent to $0.555 quarterly. Shares outstanding fell from 562.8 million to 557.8 million, a 0.9 percent reduction. Full-year guidance calls for about $2.2 billion returned — $1.0 billion of repurchases and $1.2 billion of dividends — against roughly $3.6 billion of expected free cash flow. Comfortably covered, with room left over.
4. What Else Matters
Test & Measurement finally works. This is the quarter's most important operational fact. The NI-branded unit swung from a $26 million loss to $11 million of profit, on sales up 23 percent to $445 million — all of it organic, with no currency or acquisition help. Management points to semiconductor and aerospace/defense demand. The turn is visible over nine months too: a $64 million loss last year became $21 million of profit this year, on sales up 18 percent to $1,268 million. Emerson acquired NI in October 2023 at an equity value of $8.2 billion, so sustained profitability here is what would begin to justify that price.
Segment scorecard (Q3).
| Segment | Sales FY25 ($M) | Sales FY26 ($M) | Chg | Earnings FY25 ($M) | Earnings FY26 ($M) | Chg | Adj. EBITA margin |
|---|---|---|---|---|---|---|---|
| Control Systems & Software | 1,120 | 1,199 | +7% | 271 | 285 | +5% | — |
| Test & Measurement | 360 | 445 | +23% | (26) | 11 | n.m. | — |
| Software & Systems | 1,480 | 1,644 | +11% | 245 | 296 | +21% | 32.1% → 31.8% |
| Sensors | 1,013 | 1,091 | +8% | 246 | 303 | +23% | — |
| Final Control | 1,522 | 1,586 | +4% | 351 | 349 | -1% | — |
| Intelligent Devices | 2,535 | 2,677 | +6% | 597 | 652 | +9% | 25.5% → 27.9% |
| Safety & Productivity | 538 | 552 | +3% | 103 | 93 | -10% | 20.4% → 21.2% |
Two segments look worse than they are. Final Control's earnings dipped 1 percent, but it absorbed $48 million of restructuring against $8 million last year. Safety & Productivity earnings fell 10 percent while carrying $17 million of restructuring versus none. Both units show adjusted EBITA margin expansion — Intelligent Devices by a striking 2.4 points. The reported earnings decline is self-inflicted cost action, not deteriorating economics.
Safety & Productivity does have a real volume problem, though. Underlying sales rose 2 percent on 4 percent higher price offset by 2 percent lower volume, with Europe down 6 percent. Price is masking shrinking unit demand.
Geography is splitting. Americas sales rose 8.4 percent to $2,537 million and now represent 52.1 percent of the total. AMEA rose 8.8 percent. Europe was effectively flat at $861 million, up just 0.6 percent, and down 1 percent underlying. Underlying U.S. sales grew 10 percent against 4 percent internationally, and China fell 3 percent. Emerson is increasingly an American infrastructure story — power generation and LNG are named repeatedly as demand drivers.
Backlog and pricing. Backlog stood at approximately $9.6 billion, with about 75 percent expected to convert to revenue within twelve months. Underlying sales rose 6 percent on an even 3 percent volume / 3 percent price split. That is a healthier balance than the nine-month figure. Over nine months, price contributed all 3 percent of underlying growth, while volume was dragged down roughly 1.5 percent by software renewal timing and the Middle East conflict.
Tax and contingencies. The effective tax rate was 22 percent versus 21 percent, with the One Big Beautiful Bill Act adding about a point through a reduced foreign-derived intangible income deduction. Management expects OBBBA to turn slightly favorable in fiscal 2027. On contingencies, this 10-Q carries no separate legal-proceedings note and discloses no "reasonably possible" loss range. Asbestos litigation liability actually declined, from $131 million to $119 million, with related insurance receivables of $50 million. Nothing here threatens the headline numbers.
Currency. Foreign currency hedge positions had a notional value of roughly $3.9 billion. Euro-denominated debt continues to serve as a net investment hedge, and contributed $50 million to other comprehensive income over nine months against negative $138 million last year. Translation still cost the company $101 million of OCI for the nine months.
5. Key Takeaways and Outlook
What grew. Software & Systems is the engine, up 11 percent with segment margin expanding 1.4 points to 18.0 percent. Within it, Test & Measurement's swing to profitability removes a multi-year drag. Sensors delivered the best profit growth of any unit at 23 percent, on power and LNG strength in the Americas. Underlying growth of 6 percent with a balanced price/volume split is a real improvement over the nine-month trend.
What is at risk. Three things. First, the earnings quality gap — GAAP EPS up 24 percent versus adjusted EPS up 13 percent — means anyone anchoring on the headline is overstating momentum, and the $82 million refund will not recur. Second, geographic concentration is increasing as Europe stagnates and China contracts; the growth story now rests heavily on U.S. power and LNG capital spending. Third, the inventory build of 13.6 percent needs the backlog to convert. If Europe and China stay weak, that inventory becomes a working capital problem rather than a demand signal. The rise in net interest expense (from $145 million to $258 million for nine months) is worth monitoring, though coverage remains comfortable.
Capital allocation. The priority order is clear and unchanged: fund modest capital expenditure at about 2 percent of sales, pay a growing dividend, buy back stock with what remains, and deleverage passively rather than aggressively. Total debt is flat year-to-date and net debt-to-net capital improved to 34.9 percent purely through cash accumulation and retained earnings. With no acquisitions in the nine months and the AspenTech integration now complete, Emerson is in a digestion phase.
Cycle position. Emerson sits in the industrial and process automation cycle, so a single quarter proves little. The multi-year continuing-operations revenue path runs $13,804 million in FY2022, $15,165 million in FY2023, $17,492 million in FY2024 and $18,016 million in FY2025. That is a three-year compound growth rate of 9.3 percent. But the shape matters more than the average: the business accelerated hard through FY2024, then decelerated sharply to 3.0 percent growth in FY2025. Fiscal 2026 guidance of roughly 5 percent total growth, with 3.5 percent underlying and 1.5 percent from currency, points to modest re-acceleration off that trough rather than a new upcycle. Management guides to approximately $4.89 of GAAP EPS and $6.55 adjusted, with operating cash flow near $4.1 billion and free cash flow near $3.6 billion.
The reasonable read is mid-cycle recovery with visible but unspectacular momentum. If U.S. power and LNG spending holds and Test & Measurement sustains its turn, the backlog supports the guided trajectory. If Europe and China stay where they are, price increases will have to keep carrying volume — and that is a harder thing to repeat in a fourth consecutive year.
Quick Notes Check
- Accounting policy — Most revenue is recognized at a point in time when control transfers; a smaller share is over-time or multi-element. Segments were restructured into five reportable units effective fiscal 2026, with prior periods reclassified.
- Segment information — Software & Systems generates 34 percent of sales but Intelligent Devices contributes the larger absolute profit at $652 million. The Americas now account for 52.1 percent of revenue.
- Debt detail — Total debt of $13,113 million with a shift toward commercial paper; $5.5 billion of undrawn committed facilities; long-term debt fair value $762 million below carrying value.
- Contingencies — No "reasonably possible" loss disclosure. Asbestos liability declining at $119 million.
- Compensation — Stock compensation of $181 million for nine months, down from $198 million; a new employee stock purchase plan commenced January 1, 2026 with up to 10 million shares authorized.
This analysis is based on filings submitted to the U.S. Securities and Exchange Commission and is provided for informational purposes only. It is not investment advice. Source: SEC Form 10-Q, filed August 4, 2026.
KOREAN_DRAFT_PATH=/home/ubuntu/linevest/보고서/Korean/agent_20260910_000054_EMERSON_ELECTRIC_CO_Q3 FY2026_한국어.md